GnRH antagonists

kasr al ainy school of Medicine Cairo University   CHANGING ATTITUDES IN OVARIAN STIMULATION
CHANGING ATTITUDE IS A FACT OF LIFE ,[object Object],[object Object]
THE BEST MODEL  ,[object Object]
WHAT ABOUT GYNECOLOGY ,[object Object]
IVF ,[object Object]
16 follicles 12 mature oocytes 14 oocytes Extras frozen if good 2 to 3 transferred 9 fertilize normally 5 divide normally 30-40% of couples 4 stop dividing & sperm Typical progression
OHSS is the most serious complication  of ovulation induction.
PROTOCOLS FOR IVF  GnRH Antagonist Protocols GnRH  Agonist Protocols   225 IU per day (150 IU Europe ) Individualized Dosing of FSH/HMG 250 mg per day antagonist Individualized Dosing of FSH/HMG GnRHa 1.0 mg per day  up to 21 days 0.5 mg per day of GnRHa 225 IU per day (150 IU Europe ) Day 6 of  FSH/HMG Day of  hCG Day 1  of FSH/HMG Day 6 of  FSH/HMG Day of hCG 7 – 8 days after estimated ovulation Down regulation Day 2 or 3 of menses Day 1  FSH/HMG
SHOULD BE EVIDENCE BASED ,[object Object],[object Object]
AL-INANY & ABOULGHAR, 2001
AL-INANY ET AL., 2006  ,[object Object]
AL-INANY  ET AL., 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IT IS JUSTIFIED TO ,[object Object]
WHY:  (AL-INANY ET AL, 2010)
HOW TO EXPLAIN ,[object Object],[object Object],[object Object],[object Object],[object Object]
NUMBER NEEDED TO HARM ,[object Object],[object Object]
CANCELLATION FOR RISK OF OHSS
CONSIDERING CYCLES CANCELLED FOR RISK OF OHSS ,[object Object],[object Object]
[object Object]
LIVE BIRTH RATE
CPR
MISCARRIAGE RATE
IN FAVOR OF ANTAGONIST ,[object Object],[object Object],[object Object]
3. 0  ampoules less with GnRH antagonists p<0.0 7   FSH requirement
1. 1  less days with antagonists p<0.001 Duration of FSH treatment
HOW TO EXPLAIN IMPROVED EFFICACY ,[object Object]
LH STABILITY: AGONIST VS. ANATGONIST
FIXED DOSE PROTOCOL
Flexible antagonist stimulation
Meta-analysis of clinical pregnancy rate in fixed and flexible protocols for GnRH antagonist protocols Al-Inany et al. 2005
FURTHER ANALYSIS ,[object Object],[object Object],[object Object],[object Object]
SO OUR CONCLUSION:  ,[object Object]
BUT NOT ALL DOCTORS WOULD GO FOR ANTAGONIST
(GNRH) ANTAGONISTS: OFF LABEL INDICATION  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VALUE ,[object Object]
 
OUR RESULTS Parameter Coasting (n = 96) Antagonist (n = 94) P-value Age (years) 30.0 ± 4.9 29.6 ± 4.6 NS Duration of infertility (years) 6.64 ± 4.45 7.07 ± 4.3 NS No. of HMG injections 30.52 ± 8.9 29.94 ± 8.8 NS Days of stimulation 1 9.1 ± 1.5 9.4 ± 1.5 NS Peak oestradiol (pg/ml) 5087 ± 1589 5305 ± 1680 NS Oestradiol on day of HCG (pg/ml) 2605 ± 790 2721 ± 699 NS Range of oestradiol on day of HCG (pg/ml)  1110–4136 1223–4093 NS Day of intervention 2.82 ± 0.97 1.74 ± 0.91 <0.0001 No. of oocytes 14.06 ± 5.20 16.5 ± 7.60 0.02 No. of MII oocytes  11.13 ± 4.60 13.14 ± 6.60 NS No. of fertilized oocytes    7.97 ± 3.80    9.14 ± 4.70 NS No. of high quality embryos    2.21 ± 1.10    2.87 ± 1.20 0.0001 No. of embryos transferred    2.83 ± 0.50    2.79 ± 0.40 NS No. of cryopreserved embryos    4.50 ± 3.93    5.77 ± 4.87 NS Clinical pregnancy (%) 46/96  (47.9) 52/94  (55.3) NS Multiple pregnancy (%) 15/46 (32.6) 17/52 (32.7) NS
THE FUTURE  ,[object Object],[object Object]
JUST A QUESTION ,[object Object]
SIMPLE, SHORTER  SAFER
WHY CHANGING ATTITUDE  ,[object Object],[object Object]
THANK YOU Dr. Hesham Al-Inany  MD, PhD e-mail : hesham@khosoba.com
1 von 42

Recomendados

Individualizing Ovarian Stimulation Protocols for IVF von
Individualizing Ovarian Stimulation Protocols for IVFIndividualizing Ovarian Stimulation Protocols for IVF
Individualizing Ovarian Stimulation Protocols for IVFSherInstitute
12.1K views42 Folien
Ovarian Stimulation Protocols von
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation ProtocolsHesham Gaber
74.2K views66 Folien
Management of poor ovarian response von
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
7.2K views34 Folien
Management of thin endometrium isar 2019 von
Management of thin endometrium isar 2019Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Poonam Loomba
2.2K views59 Folien
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI von
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANIDR SHASHWAT JANI
4.3K views45 Folien

Más contenido relacionado

Was ist angesagt?

Recent updates in ovulation induction in pcos von
Recent updates in ovulation induction in  pcosRecent updates in ovulation induction in  pcos
Recent updates in ovulation induction in pcosDr. Sunita Chandra
239 views61 Folien
POOR RESPONDERS: Minimal Vs. Maximal stimulation von
POOR RESPONDERS: Minimal Vs. Maximal stimulationPOOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulationAboubakr Elnashar
2.2K views11 Folien
Gonadotrpin ovarian stimulation: Aboubakr elnashar von
Gonadotrpin ovarian stimulation: Aboubakr elnasharGonadotrpin ovarian stimulation: Aboubakr elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnasharAboubakr Elnashar
4.3K views53 Folien
Controlled ovarian stimulation in IVF von
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFAboubakr Elnashar
19.9K views52 Folien
Ovarian stimulation von
Ovarian stimulationOvarian stimulation
Ovarian stimulationAboubakr Elnashar
3.2K views39 Folien
Adjuvants in por (1) von
Adjuvants in por (1)Adjuvants in por (1)
Adjuvants in por (1)rupalibassi
272 views46 Folien

Was ist angesagt?(20)

POOR RESPONDERS: Minimal Vs. Maximal stimulation von Aboubakr Elnashar
POOR RESPONDERS: Minimal Vs. Maximal stimulationPOOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulation
Aboubakr Elnashar2.2K views
Gonadotrpin ovarian stimulation: Aboubakr elnashar von Aboubakr Elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnasharGonadotrpin ovarian stimulation: Aboubakr elnashar
Gonadotrpin ovarian stimulation: Aboubakr elnashar
Aboubakr Elnashar4.3K views
Controlled ovarian stimulation in IVF von Aboubakr Elnashar
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVF
Aboubakr Elnashar19.9K views
Adjuvants in por (1) von rupalibassi
Adjuvants in por (1)Adjuvants in por (1)
Adjuvants in por (1)
rupalibassi272 views
Unexplained Infertility - By Dr Dhorepatil Bharati von Bharati Dhorepatil
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil Bharati
Bharati Dhorepatil2.3K views
Progestin-primed ovarian stimulation (PPOS) is a NEW DAW... von Lifecare Centre
Progestin-primed ovarian stimulation (PPOS)                      is a NEW DAW...Progestin-primed ovarian stimulation (PPOS)                      is a NEW DAW...
Progestin-primed ovarian stimulation (PPOS) is a NEW DAW...
Lifecare Centre2.5K views
Recent advances in stimulation protocols von Sandro Esteves
Recent advances in stimulation protocolsRecent advances in stimulation protocols
Recent advances in stimulation protocols
Sandro Esteves10.2K views
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF von Aboubakr Elnashar
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
Aboubakr Elnashar2.2K views
How to stimulate your patient for IVF / ICSI von Hesham Al-Inany
How to stimulate your patient for IVF / ICSIHow to stimulate your patient for IVF / ICSI
How to stimulate your patient for IVF / ICSI
Hesham Al-Inany4.9K views
Monitoring of IVF Cycle - Dr Dhorepatil Bharati von Bharati Dhorepatil
Monitoring of IVF Cycle - Dr Dhorepatil BharatiMonitoring of IVF Cycle - Dr Dhorepatil Bharati
Monitoring of IVF Cycle - Dr Dhorepatil Bharati
Bharati Dhorepatil2.7K views
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati... von DR SHASHWAT JANI
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
Panel IUI by DR SHASHWAT JANI ( Optimizing Success in Intrauterine Inseminati...
DR SHASHWAT JANI3.3K views
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha... von Lifecare Centre
 IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha... IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha...
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
Lifecare Centre6.3K views
Top Five Problems You Have with Ovulation Induction and How to Solve Them von Sandro Esteves
Top Five Problems You Have with Ovulation Induction and How to Solve ThemTop Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve Them
Sandro Esteves5K views

Destacado

GnRH Agonists & Antagonists von
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & AntagonistsManas Nath
18.1K views44 Folien
GnRH Antagonists in Controlled Ovarian Stimulation von
GnRH Antagonists in Controlled Ovarian StimulationGnRH Antagonists in Controlled Ovarian Stimulation
GnRH Antagonists in Controlled Ovarian StimulationSandro Esteves
4.9K views26 Folien
GnRH agonist versus antagonist and impact on cycle outcome von
GnRH agonist versus antagonist and impact on cycle outcomeGnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeSandro Esteves
5K views35 Folien
Management of poor ovarian response von
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
7.6K views40 Folien
GnRH Agonist vs GnRH Antagonist what to choose? von
GnRH Agonist vs GnRH Antagonist what to choose?GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?DrRitu Santwani
1.6K views45 Folien
Gonadotropin Releasing Hormone (GnRH) von
Gonadotropin Releasing Hormone (GnRH)Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Nazmul Ahmed Oli
4.3K views3 Folien

Destacado(20)

GnRH Agonists & Antagonists von Manas Nath
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & Antagonists
Manas Nath18.1K views
GnRH Antagonists in Controlled Ovarian Stimulation von Sandro Esteves
GnRH Antagonists in Controlled Ovarian StimulationGnRH Antagonists in Controlled Ovarian Stimulation
GnRH Antagonists in Controlled Ovarian Stimulation
Sandro Esteves4.9K views
GnRH agonist versus antagonist and impact on cycle outcome von Sandro Esteves
GnRH agonist versus antagonist and impact on cycle outcomeGnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcome
Sandro Esteves5K views
Management of poor ovarian response von Hesham Gaber
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
Hesham Gaber7.6K views
GnRH Agonist vs GnRH Antagonist what to choose? von DrRitu Santwani
GnRH Agonist vs GnRH Antagonist what to choose?GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?
DrRitu Santwani1.6K views
Gonadotropin Releasing Hormone (GnRH) von Nazmul Ahmed Oli
Gonadotropin Releasing Hormone (GnRH)Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)
Nazmul Ahmed Oli4.3K views
Optimizing Treatment Outcome in ART von Sandro Esteves
Optimizing Treatment Outcome in ARTOptimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ART
Sandro Esteves2.6K views
Agonists and antagonists in controlled ovarian stimulation von Sandro Esteves
Agonists and antagonists in controlled ovarian stimulationAgonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulation
Sandro Esteves8.4K views
Individualization von t7260678
IndividualizationIndividualization
Individualization
t72606782.8K views
C.1 menstrual cycle von serenaasya
C.1   menstrual cycleC.1   menstrual cycle
C.1 menstrual cycle
serenaasya4.8K views
Physiology of labor. Anaesthesia in labor von berbets
Physiology of labor. Anaesthesia in laborPhysiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in labor
berbets4.4K views
R lh supplementation to rfsh in gnrh antagonist cycles von Alfredo Nazzaro
R lh supplementation to rfsh in gnrh antagonist cyclesR lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cycles
Alfredo Nazzaro934 views
Abortion & ectopic pregnancy by liza tarca, md von Liza Tarca
Abortion & ectopic pregnancy by liza tarca, mdAbortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, md
Liza Tarca1K views
Tema 27 _anticancerosos_bis von slayerail
Tema 27 _anticancerosos_bisTema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bis
slayerail1.7K views
Individualization of Patient Treatment von Sandro Esteves
Individualization of Patient TreatmentIndividualization of Patient Treatment
Individualization of Patient Treatment
Sandro Esteves2.7K views

Similar a GnRH antagonists

GnRH Agonist Versus GnRH Antagonist von
GnRH Agonist Versus GnRH AntagonistGnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH AntagonistDr. Snehal Dhobale Kohale
1K views38 Folien
High responders von
High respondersHigh responders
High respondersHesham Gaber
1.7K views42 Folien
Ovarian hyper stimulation syndrome ohss von
Ovarian hyper stimulation syndrome ohssOvarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohssDr.Laxmi Agrawal Shrikhande
9.1K views54 Folien
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda von
GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda umfrfouda
981 views39 Folien
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil von
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilBharati Dhorepatil
789 views81 Folien
ovarian stimulation : a 2018 update von
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateHesham Al-Inany
4.2K views56 Folien

Similar a GnRH antagonists(20)

GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda von umfrfouda
GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
umfrfouda981 views
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil von Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
Bharati Dhorepatil789 views
ovarian stimulation : a 2018 update von Hesham Al-Inany
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 update
Hesham Al-Inany4.2K views
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,... von DelhiGynaecologistForum
OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
Medical managment of ovarian hyperstimulation von Lifecare Centre
Medical managment of ovarian hyperstimulationMedical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulation
Lifecare Centre977 views
New developments in reproductive medicine (1) von 鋒博 蔡
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
鋒博 蔡152 views
New developments in reproductive medicine von 鋒博 蔡
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
鋒博 蔡106 views
New developments in reproductive medicine von 鋒博 蔡
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
鋒博 蔡340 views
New developments in reproductive medicine (1) von 鋒博 蔡
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
鋒博 蔡194 views
New developments in reproductive medicine (1) von t7260678
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
t7260678441 views
複製 New developments in reproductive medicine von t7260678
複製  New developments in reproductive medicine複製  New developments in reproductive medicine
複製 New developments in reproductive medicine
t7260678364 views
New developments in reproductive medicine von t7260678
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
t7260678333 views
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030... von Candido Tomás
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
Candido Tomás211 views

Más de Hesham Gaber

Prognostic models von
Prognostic modelsPrognostic models
Prognostic modelsHesham Gaber
2.7K views49 Folien
Poor von
PoorPoor
PoorHesham Gaber
541 views4 Folien
Infertility von
InfertilityInfertility
InfertilityHesham Gaber
276.1K views41 Folien
So much evidence 1 von
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
12 views30 Folien
So much evidence 1 von
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
798 views30 Folien
Contraception von
ContraceptionContraception
ContraceptionHesham Gaber
954 views20 Folien

Más de Hesham Gaber(20)

Pattern of vitamin d receptor polymorphism von Hesham Gaber
Pattern of vitamin d receptor polymorphism Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism
Hesham Gaber1.2K views
Why to know statistics von Hesham Gaber
Why to know statisticsWhy to know statistics
Why to know statistics
Hesham Gaber696 views
Systematic review von Hesham Gaber
Systematic reviewSystematic review
Systematic review
Hesham Gaber16.7K views
Statistics & infertility von Hesham Gaber
Statistics & infertilityStatistics & infertility
Statistics & infertility
Hesham Gaber2.6K views
Research methodology 101 von Hesham Gaber
Research methodology 101Research methodology 101
Research methodology 101
Hesham Gaber2.3K views
Randomised controlled trials von Hesham Gaber
Randomised controlled trialsRandomised controlled trials
Randomised controlled trials
Hesham Gaber36.4K views
Ovarian hyperstimulation syndrome von Hesham Gaber
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome
Hesham Gaber4.6K views
Management of ovarian cysts in postmenopausal women von Hesham Gaber
Management of ovarian cysts in postmenopausal womenManagement of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal women
Hesham Gaber14.1K views

Último

Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf von
 Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf
Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdfTechSoup
62 views28 Folien
Java Simplified: Understanding Programming Basics von
Java Simplified: Understanding Programming BasicsJava Simplified: Understanding Programming Basics
Java Simplified: Understanding Programming BasicsAkshaj Vadakkath Joshy
663 views155 Folien
NodeJS and ExpressJS.pdf von
NodeJS and ExpressJS.pdfNodeJS and ExpressJS.pdf
NodeJS and ExpressJS.pdfArthyR3
50 views17 Folien
What is Digital Transformation? von
What is Digital Transformation?What is Digital Transformation?
What is Digital Transformation?Mark Brown
41 views11 Folien
DISTILLATION.pptx von
DISTILLATION.pptxDISTILLATION.pptx
DISTILLATION.pptxAnupkumar Sharma
75 views47 Folien
Career Building in AI - Technologies, Trends and Opportunities von
Career Building in AI - Technologies, Trends and OpportunitiesCareer Building in AI - Technologies, Trends and Opportunities
Career Building in AI - Technologies, Trends and OpportunitiesWebStackAcademy
47 views44 Folien

Último(20)

Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf von TechSoup
 Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf
Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf
TechSoup 62 views
NodeJS and ExpressJS.pdf von ArthyR3
NodeJS and ExpressJS.pdfNodeJS and ExpressJS.pdf
NodeJS and ExpressJS.pdf
ArthyR350 views
What is Digital Transformation? von Mark Brown
What is Digital Transformation?What is Digital Transformation?
What is Digital Transformation?
Mark Brown41 views
Career Building in AI - Technologies, Trends and Opportunities von WebStackAcademy
Career Building in AI - Technologies, Trends and OpportunitiesCareer Building in AI - Technologies, Trends and Opportunities
Career Building in AI - Technologies, Trends and Opportunities
WebStackAcademy47 views
JRN 362 - Lecture Twenty-Three (Epilogue) von Rich Hanley
JRN 362 - Lecture Twenty-Three (Epilogue)JRN 362 - Lecture Twenty-Three (Epilogue)
JRN 362 - Lecture Twenty-Three (Epilogue)
Rich Hanley43 views
UNIT NO 13 ORGANISMS AND POPULATION.pptx von Madhuri Bhande
UNIT NO 13 ORGANISMS AND POPULATION.pptxUNIT NO 13 ORGANISMS AND POPULATION.pptx
UNIT NO 13 ORGANISMS AND POPULATION.pptx
Madhuri Bhande43 views
Retail Store Scavenger Hunt.pptx von jmurphy154
Retail Store Scavenger Hunt.pptxRetail Store Scavenger Hunt.pptx
Retail Store Scavenger Hunt.pptx
jmurphy15453 views
Six Sigma Concept by Sahil Srivastava.pptx von Sahil Srivastava
Six Sigma Concept by Sahil Srivastava.pptxSix Sigma Concept by Sahil Srivastava.pptx
Six Sigma Concept by Sahil Srivastava.pptx
Sahil Srivastava51 views
Creative Restart 2023: Atila Martins - Craft: A Necessity, Not a Choice von Taste
Creative Restart 2023: Atila Martins - Craft: A Necessity, Not a ChoiceCreative Restart 2023: Atila Martins - Craft: A Necessity, Not a Choice
Creative Restart 2023: Atila Martins - Craft: A Necessity, Not a Choice
Taste52 views
Creative Restart 2023: Leonard Savage - The Permanent Brief: Unearthing unobv... von Taste
Creative Restart 2023: Leonard Savage - The Permanent Brief: Unearthing unobv...Creative Restart 2023: Leonard Savage - The Permanent Brief: Unearthing unobv...
Creative Restart 2023: Leonard Savage - The Permanent Brief: Unearthing unobv...
Taste62 views
ANGULARJS.pdf von ArthyR3
ANGULARJS.pdfANGULARJS.pdf
ANGULARJS.pdf
ArthyR352 views
INT-244 Topic 6b Confucianism von S Meyer
INT-244 Topic 6b ConfucianismINT-244 Topic 6b Confucianism
INT-244 Topic 6b Confucianism
S Meyer49 views
Payment Integration using Braintree Connector | MuleSoft Mysore Meetup #37 von MysoreMuleSoftMeetup
Payment Integration using Braintree Connector | MuleSoft Mysore Meetup #37Payment Integration using Braintree Connector | MuleSoft Mysore Meetup #37
Payment Integration using Braintree Connector | MuleSoft Mysore Meetup #37

GnRH antagonists

  • 1. kasr al ainy school of Medicine Cairo University CHANGING ATTITUDES IN OVARIAN STIMULATION
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. 16 follicles 12 mature oocytes 14 oocytes Extras frozen if good 2 to 3 transferred 9 fertilize normally 5 divide normally 30-40% of couples 4 stop dividing & sperm Typical progression
  • 7. OHSS is the most serious complication of ovulation induction.
  • 8. PROTOCOLS FOR IVF GnRH Antagonist Protocols GnRH Agonist Protocols 225 IU per day (150 IU Europe ) Individualized Dosing of FSH/HMG 250 mg per day antagonist Individualized Dosing of FSH/HMG GnRHa 1.0 mg per day up to 21 days 0.5 mg per day of GnRHa 225 IU per day (150 IU Europe ) Day 6 of FSH/HMG Day of hCG Day 1 of FSH/HMG Day 6 of FSH/HMG Day of hCG 7 – 8 days after estimated ovulation Down regulation Day 2 or 3 of menses Day 1 FSH/HMG
  • 9.
  • 11.
  • 12.
  • 13.
  • 14. WHY: (AL-INANY ET AL, 2010)
  • 15.
  • 16.
  • 18.
  • 19.
  • 21. CPR
  • 23.
  • 24. 3. 0 ampoules less with GnRH antagonists p<0.0 7 FSH requirement
  • 25. 1. 1 less days with antagonists p<0.001 Duration of FSH treatment
  • 26.
  • 27. LH STABILITY: AGONIST VS. ANATGONIST
  • 30. Meta-analysis of clinical pregnancy rate in fixed and flexible protocols for GnRH antagonist protocols Al-Inany et al. 2005
  • 31.
  • 32.
  • 33. BUT NOT ALL DOCTORS WOULD GO FOR ANTAGONIST
  • 34.
  • 35.
  • 36.  
  • 37. OUR RESULTS Parameter Coasting (n = 96) Antagonist (n = 94) P-value Age (years) 30.0 ± 4.9 29.6 ± 4.6 NS Duration of infertility (years) 6.64 ± 4.45 7.07 ± 4.3 NS No. of HMG injections 30.52 ± 8.9 29.94 ± 8.8 NS Days of stimulation 1 9.1 ± 1.5 9.4 ± 1.5 NS Peak oestradiol (pg/ml) 5087 ± 1589 5305 ± 1680 NS Oestradiol on day of HCG (pg/ml) 2605 ± 790 2721 ± 699 NS Range of oestradiol on day of HCG (pg/ml) 1110–4136 1223–4093 NS Day of intervention 2.82 ± 0.97 1.74 ± 0.91 <0.0001 No. of oocytes 14.06 ± 5.20 16.5 ± 7.60 0.02 No. of MII oocytes 11.13 ± 4.60 13.14 ± 6.60 NS No. of fertilized oocytes   7.97 ± 3.80   9.14 ± 4.70 NS No. of high quality embryos   2.21 ± 1.10   2.87 ± 1.20 0.0001 No. of embryos transferred   2.83 ± 0.50   2.79 ± 0.40 NS No. of cryopreserved embryos   4.50 ± 3.93   5.77 ± 4.87 NS Clinical pregnancy (%) 46/96 (47.9) 52/94 (55.3) NS Multiple pregnancy (%) 15/46 (32.6) 17/52 (32.7) NS
  • 38.
  • 39.
  • 41.
  • 42. THANK YOU Dr. Hesham Al-Inany MD, PhD e-mail : hesham@khosoba.com

Hinweis der Redaktion

  1. 06/28/11
  2. 06/28/11
  3. 06/28/11
  4. * *
  5. * *
  6. 06/28/11
  7. IBSA Institut Biochimique SA 28/06/11